Using QALYs in Cancer
- 1 August 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in PharmacoEconomics
- Vol. 29 (8), 673-685
- https://doi.org/10.2165/11588250-000000000-00000
Abstract
The objective of this paper is to examine how well the QALY captures the health gains generated by cancer treatments, with particular focus on the methods for constructing QALYs preferred by the UK National Institute for Health and Clinical Excellence (NICE). Data were obtained using a keyword search of the MEDLINE database and a hand search of articles written by leading researchers in the subject area (with follow up of the references in these articles). Key arguments were discussed and developed at an oncology workshop in September 2009 at the Office of Health Economics. Three key issues emerged. First, the EQ-5D, NICE’s preferred measure of health-related quality of life (QOL) in adults, has been found to be relatively insensitive to changes in health status of cancer patients. Second, the time trade-off, NICEs preferred technique for estimating the values of health states, involves making assumptions that are likely to be violated in end-of-life scenarios. Third, the practice of using valuations of members of the general population, as recommended by NICE, is problematic because such individuals typically display a misunderstanding of what it is really like for patients to live with cancer. Because of the way in which it is constructed, the QALY shows important limitations in terms of its ability to accurately capture the value of the health gains deemed important by cancer patients. A research agenda for addressing these limitations is proposed.Keywords
This publication has 59 references indexed in Scilit:
- On the (not so) constant proportional trade-off in TTOQuality of Life Research, 2010
- Comparative Effectiveness and Health Care Spending — Implications for ReformThe New England Journal of Medicine, 2010
- Do neurooncological patients and their significant others agree on quality of life ratings?Health and Quality of Life Outcomes, 2009
- Reliability and validity of a new scale on internal coherence (ICS) of cancer patientsHealth and Quality of Life Outcomes, 2009
- Estimation of a Preference-Based Index from a Condition-Specific Measure: The King's Health QuestionnaireMedical Decision Making, 2007
- An assessment of the discriminative ability of the EQ-5Dindex, SF-6D, and EQ VAS, using sociodemographic factors and clinical conditionsThe European Journal of Health Economics, 2007
- The validity of time trade-off values in calculating QALYs: constant proportional time trade-off versus the proportional heuristicJournal of Health Economics, 2003
- Cancer-related fatigue - a difference of opinion? Results of a multicentre survey of healthcare professionals, patients and caregiversEuropean Journal of Cancer Care, 2003
- EQ-SD: a measure of health status from the EuroQol GroupAnnals of Medicine, 2001
- Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.BMJ, 1990